DEXCOM INC·4

Mar 10, 4:00 PM ET

Lawver Teri L 4

4 · DEXCOM INC · Filed Mar 10, 2023

Insider Transaction Report

Form 4
Period: 2023-03-08
Lawver Teri L
EVP Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2023-03-08$0.00/sh+45,352$4545,352 total
Footnotes (2)
  • [F1]Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in four equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
  • [F2]Included in this number are 45,352 unvested restricted stock units, 45,352 of which were granted on March 8, 2023 and shall vest through March 8, 2027.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT